TNSN06298A1 - Disintegrating tablets comprising licarbazepine - Google Patents

Disintegrating tablets comprising licarbazepine

Info

Publication number
TNSN06298A1
TNSN06298A1 TNP2006000298A TNSN06298A TNSN06298A1 TN SN06298 A1 TNSN06298 A1 TN SN06298A1 TN P2006000298 A TNP2006000298 A TN P2006000298A TN SN06298 A TNSN06298 A TN SN06298A TN SN06298 A1 TNSN06298 A1 TN SN06298A1
Authority
TN
Tunisia
Prior art keywords
licarbazepine
disintegrating tablets
dibenz
azepine
carboxamide
Prior art date
Application number
TNP2006000298A
Other languages
English (en)
French (fr)
Inventor
Marie-Christine Wolf
Oskar Kalb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/002987 external-priority patent/WO2005092290A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TNSN06298A1 publication Critical patent/TNSN06298A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
TNP2006000298A 2004-03-22 2006-09-21 Disintegrating tablets comprising licarbazepine TNSN06298A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0406381A GB0406381D0 (en) 2004-03-22 2004-03-22 Organic compounds
PCT/EP2005/002987 WO2005092290A1 (en) 2004-03-22 2005-03-21 Disintegrating tablets comprising licarbazepine

Publications (1)

Publication Number Publication Date
TNSN06298A1 true TNSN06298A1 (en) 2007-12-03

Family

ID=32118145

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000298A TNSN06298A1 (en) 2004-03-22 2006-09-21 Disintegrating tablets comprising licarbazepine

Country Status (3)

Country Link
CN (1) CN1933817A (zh)
GB (1) GB0406381D0 (zh)
TN (1) TNSN06298A1 (zh)

Also Published As

Publication number Publication date
GB0406381D0 (en) 2004-04-21
CN1933817A (zh) 2007-03-21

Similar Documents

Publication Publication Date Title
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
GEP20125565B (en) Lactam compounds and their pharmaceutical use
UA96449C2 (en) Stable laquinimod preparations
HK1077515A1 (zh) 水溶性藥性成分
IL178689A0 (en) Pharmaceutical solution formulations containing 17-aag
NO20064808L (no) Orale matrixformuleringer med licarbazepin
WO2005009387A3 (en) Azepine derivatives as pharmaceutical agents
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
NO20064783L (no) Opplosningstabeletter med licarbazepin
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
TW200531686A (en) Pharmaceutical compositions
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
IL179014A0 (en) Film-shaped medicament for oral administration, containing estriol
UA87152C2 (ru) Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
ZA200501010B (en) BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.
TNSN06298A1 (en) Disintegrating tablets comprising licarbazepine
GB0620619D0 (en) Novel compounds
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
GB0327390D0 (en) Pharmaceutical formulations
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine
WO2007052300A3 (en) Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate